Cannabis Report
Home > Boards > US OTC > Medical - Drugs > Innovation Pharmaceuticals Inc. (IPIX)

That's called a Type 2 error and well

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
frrol Member Profile
Member Level 
Followed By 57
Posts 6,114
Boards Moderated 0
Alias Born 06/06/14
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 6/29/2018 2:11:50 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/29/2018 7:24:52 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/10/2018 4:14:20 PM
Traders News Issues Research on High Growth Canna and Pharma Stocks InvestorsHub NewsWire - 4/25/2018 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/16/2018 1:18:08 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/9/2018 3:04:31 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 2/7/2018 4:59:15 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/11/2018 4:35:53 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/27/2017 3:08:40 PM
Prospectus Filed Pursuant to Rule 424(b)(2) (424b2) Edgar (US Regulatory) - 11/13/2017 10:03:05 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/8/2017 4:04:57 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 9/22/2017 6:02:17 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 9/11/2017 12:47:10 PM
Annual Report (10-k) Edgar (US Regulatory) - 9/11/2017 6:04:38 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 9/11/2017 6:04:37 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/6/2017 6:27:18 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/6/2017 6:24:45 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/8/2017 4:18:08 PM
Annual Statement of Changes in Beneficial Ownership (5) Edgar (US Regulatory) - 8/8/2017 4:17:33 PM
Annual Statement of Changes in Beneficial Ownership (5) Edgar (US Regulatory) - 8/8/2017 4:17:00 PM
Annual Statement of Changes in Beneficial Ownership (5) Edgar (US Regulatory) - 8/8/2017 4:16:36 PM
frrol Member Level  Friday, 01/12/18 04:23:09 PM
Re: PlentyParanoid post# 212618
Post # of 235042 
That's called a Type 2 error and well known to happen, post hoc. Of course, there are also Type 1 errors which are the opposite: concluding the drug works when it does not.

But a researcher cannot design a test, decide the n and confidence interval, perform the test, attest to proper design and performance, and then disavow the conclusions when he doesn't like them.

What he can do is keep testing.


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist